186 related articles for article (PubMed ID: 24423398)
1. Quantitative proteomic analysis of sphere-forming stem-like oral cancer cells.
Misuno K; Liu X; Feng S; Hu S
Stem Cell Res Ther; 2013; 4(6):156. PubMed ID: 24423398
[TBL] [Abstract][Full Text] [Related]
2. H⁺-myo-inositol transporter SLC2A13 as a potential marker for cancer stem cells in an oral squamous cell carcinoma.
Lee DG; Lee JH; Choi BK; Kim MJ; Kim SM; Kim KS; Chang K; Park SH; Bae YS; Kwon BS
Curr Cancer Drug Targets; 2011 Oct; 11(8):966-75. PubMed ID: 21861841
[TBL] [Abstract][Full Text] [Related]
3. TMT-based quantitative proteomic analysis of spheroid cells of endometrial cancer possessing cancer stem cell properties.
Cao M; Liu Z; You D; Pan Y; Zhang Q
Stem Cell Res Ther; 2023 May; 14(1):119. PubMed ID: 37143105
[TBL] [Abstract][Full Text] [Related]
4. Leading edge or tumor core: Intratumor cancer stem cell niches in oral cavity squamous cell carcinoma and their association with stem cell function.
Chowdhury FN; Reisinger J; Gomez KE; Chimed TS; Thomas CM; Le PN; Miller B; Morton JJ; Nieto CM; Somerset HL; Wang XJ; Keysar SB; Jimeno A
Oral Oncol; 2019 Nov; 98():118-124. PubMed ID: 31586893
[TBL] [Abstract][Full Text] [Related]
5. Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.
Corominas-Faja B; Cufí S; Oliveras-Ferraros C; Cuyàs E; López-Bonet E; Lupu R; Alarcón T; Vellon L; Iglesias JM; Leis O; Martín ÁG; Vazquez-Martin A; Menendez JA
Cell Cycle; 2013 Sep; 12(18):3109-24. PubMed ID: 23974095
[TBL] [Abstract][Full Text] [Related]
6. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
Bourguignon LY; Wong G; Earle C; Chen L
J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
[TBL] [Abstract][Full Text] [Related]
9. Role of Telomeric TRF2 in Orosphere Formation and CSC Phenotype Maintenance Through Efficient DNA Repair Pathway and its Correlation with Recurrence in OSCC.
Saha A; Roy S; Kar M; Roy S; Thakur S; Padhi S; Akhter Y; Banerjee B
Stem Cell Rev Rep; 2018 Dec; 14(6):871-887. PubMed ID: 29872959
[TBL] [Abstract][Full Text] [Related]
10. STON2 negatively modulates stem-like properties in ovarian cancer cells via DNMT1/MUC1 pathway.
Xu S; Yue Y; Zhang S; Zhou C; Cheng X; Xie X; Wang X; Lu W
J Exp Clin Cancer Res; 2018 Dec; 37(1):305. PubMed ID: 30518424
[TBL] [Abstract][Full Text] [Related]
11. Plasma membrane proteomics of tumor spheres identify CD166 as a novel marker for cancer stem-like cells in head and neck squamous cell carcinoma.
Yan M; Yang X; Wang L; Clark D; Zuo H; Ye D; Chen W; Zhang P
Mol Cell Proteomics; 2013 Nov; 12(11):3271-84. PubMed ID: 23903875
[TBL] [Abstract][Full Text] [Related]
12. CD44(high)CD24(low) molecular signature determines the Cancer Stem Cell and EMT phenotype in Oral Squamous Cell Carcinoma.
Ghuwalewala S; Ghatak D; Das P; Dey S; Sarkar S; Alam N; Panda CK; Roychoudhury S
Stem Cell Res; 2016 Mar; 16(2):405-17. PubMed ID: 26926234
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis reveals that CD147/EMMPRIN confers chemoresistance in cancer stem cell-like cells.
Kang MJ; Kim HP; Lee KS; Yoo YD; Kwon YT; Kim KM; Kim TY; Yi EC
Proteomics; 2013 May; 13(10-11):1714-25. PubMed ID: 23554123
[TBL] [Abstract][Full Text] [Related]
14. MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells.
Han M; Wang Y; Liu M; Bi X; Bao J; Zeng N; Zhu Z; Mo Z; Wu C; Chen X
Cancer Sci; 2012 Jun; 103(6):1058-64. PubMed ID: 22435731
[TBL] [Abstract][Full Text] [Related]
15. Comparative proteomic analysis of oral squamous cell carcinoma and adjacent non-tumour tissue from Thailand.
Chanthammachat P; Promwikorn W; Pruegsanusak K; Roytrakul S; Srisomsap C; Chokchaichamnankit D; Svasti J; Boonyaphiphat P; K S; Thongsuksai P
Arch Oral Biol; 2013 Nov; 58(11):1677-85. PubMed ID: 24112734
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid hydrogels with defined crosslink density for the efficient enrichment of breast cancer stem cells.
Tan S; Yamashita A; Gao SJ; Kurisawa M
Acta Biomater; 2019 Aug; 94():320-329. PubMed ID: 31125725
[TBL] [Abstract][Full Text] [Related]
17. Disclosure of a stem cell phenotype in an oral squamous cell carcinoma cell line induced by BMP-4 via an epithelial-mesenchymal transition.
Qiao B; Johnson NW; Chen X; Li R; Tao Q; Gao J
Oncol Rep; 2011 Aug; 26(2):455-61. PubMed ID: 21567100
[TBL] [Abstract][Full Text] [Related]
18. QKI impairs self-renewal and tumorigenicity of oral cancer cells via repression of SOX2.
Lu W; Feng F; Xu J; Lu X; Wang S; Wang L; Lu H; Wei M; Yang G; Wang L; Lu Z; Liu Y; Lei X
Cancer Biol Ther; 2014 Sep; 15(9):1174-84. PubMed ID: 24918581
[TBL] [Abstract][Full Text] [Related]
19. The inhibitory effect of hypoxic cytotoxin on the expansion of cancer stem cells in ovarian cancer.
Nozawa-Suzuki N; Nagasawa H; Ohnishi K; Morishige K
Biochem Biophys Res Commun; 2015 Feb; 457(4):706-11. PubMed ID: 25619133
[TBL] [Abstract][Full Text] [Related]
20. Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State.
Chien CS; Wang ML; Chu PY; Chang YL; Liu WH; Yu CC; Lan YT; Huang PI; Lee YY; Chen YW; Lo WL; Chiou SH
Cancer Res; 2015 Jun; 75(12):2553-65. PubMed ID: 25858147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
